Literature DB >> 22828166

Orbital lymphangiomas: a review of management strategies.

Konal Saha1, Brian Leatherbarrow.   

Abstract

PURPOSE OF REVIEW: Orbital lymphangiomas present a difficult management problem for the ophthalmologist. This review offers a strategy for managing the condition. RECENT
FINDINGS: There have been recent publications discussing the use of intralesional fibrin glue to aid dissection and intralesional sclerosant to shrink the lesion. We discuss the evidence for these treatments and present a case in which these treatments were combined.
SUMMARY: This review highlights the classification and presents management options for orbital lymphangioma. We encourage a holistic and individualized approach to the patients, recognizing the variety of clinical manifestations that the condition can cause. In the event of surgical excision, we present the evidence for the use of intralesional fibrin glue and intralesional sclerosant, and describe using both in the same case.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828166     DOI: 10.1097/ICU.0b013e3283560a99

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  8 in total

1.  Successful treatment of orbital lymphangioma with intralesional bleomycin and application of continuous negative pressure.

Authors:  Ka Hyun Lee; Sun Hyup Han; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2015-02

2.  Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations.

Authors:  N Bothra; L Panda; J Sheth; D Tripathy
Journal:  Eye (Lond)       Date:  2017-08-04       Impact factor: 3.775

3.  Surgical Reconstruction of Ocular Surface Tumors Using Fibrin Sealant Tissue Adhesive.

Authors:  Aline Roseane Queiroz de Paiva; Larissa Abreu de Azevedo Fraga; Virgínia Laura Lucas Torres
Journal:  Ocul Oncol Pathol       Date:  2016-03-15

Review 4.  Sclerotherapy for Orbital Lymphangioma - Case Series and Literature Review.

Authors:  Karnesh Chandrakant Patel; George Kalantzis; Nabil El-Hindy; Bernard Y Chang
Journal:  In Vivo       Date:  2017 Mar-Apr       Impact factor: 2.155

5.  Interventions for orbital lymphangioma.

Authors:  Sheel R Patel; Jamie B Rosenberg; Anne Barmettler
Journal:  Cochrane Database Syst Rev       Date:  2019-05-15

Review 6.  [Sclerotization of orbital lymphangioma with OK-432].

Authors:  W Lagrèze; M Metzger; J Rössler
Journal:  Ophthalmologe       Date:  2014-05       Impact factor: 1.059

7.  Orbital Lymphangioma: Characteristics and Treatment Outcomes of 12 Cases.

Authors:  Young Jun Woo; Chang Yeom Kim; Bradford Sgrignoli; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2017-05-12

8.  Reversal of vision after bleomycin injection in orbital lymphangioma.

Authors:  Pratheeba Devi Nivean; Nivean Madhivanan
Journal:  GMS Ophthalmol Cases       Date:  2022-03-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.